-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BE3IWm/bMrCKAaVBls2WzX6iiHXu+VeN+rp8ZGriQIaCpg5OCxMcr4jdXQpAYZT3 AsG7zf/W4at1OpwHjXbdjw== 0000891836-03-000542.txt : 20030919 0000891836-03-000542.hdr.sgml : 20030919 20030919165203 ACCESSION NUMBER: 0000891836-03-000542 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030919 EFFECTIVENESS DATE: 20030919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 03902997 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 sc0275-03.txt FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2003 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue -------------------------------------------- New York, NY 10021-8029 -------------------------------------------- -------------------------------------------- Form 13F File Number: 28-____________ The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-521-2418 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. September 19, 2003 - --------------------- -------------------- -------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [x] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ------------------ Form 13F Information Table Entry Total: 28 ------------------ Form 13F Information Table Entry Value: 255,506 ------------------ (thousands) List of Other Included Managers: None
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER NAME OF ISSUER TITLE OF CLASS CUSIP (x1000) PRN AMT PRN CALL DISCRETION MANAGERS - -------------- -------------- ----- ------- ------- --- ---- ---------- -------- Aclara Biosciences COM 00461P106 98 23,199 SH SOLE Alexion Pharmaceuticals COM 015351109 2,884 169,663 SH SOLE Amylin Pharmaceuticals COM 032346108 23,413 1,064,232 SH SOLE Arena Pharmaceuticals COM 040047102 272 40,800 SH SOLE Autoimmune COM 052776101 42 26,100 SH SOLE Encysive Pharmaceuticals COM 29256X107 379 79,312 SH SOLE Exelixis COM 30161Q104 136 19,709 SH SOLE Human Genome Sciences COM 444903108 4,174 329,977 SH SOLE Incyte COM 45337C102 8,125 1,671,870 SH SOLE Intrabiotics Pharmaceuticals COM 46116T506 215 53,688 SH SOLE King Parmaceuticals COM 495582108 1,771 120,000 SH SOLE Kosan Biosciences COM 50064W107 169 28,935 SH SOLE Medarex COM 583916101 900 138,111 SH SOLE Neurogen COM 64124E106 3,272 683,100 SH SOLE Pharmacyclics COM 716933106 167 35,300 SH SOLE Praecis Pharmaceuticals COM 739421105 245 50,100 SH SOLE Regeneron Pharmaceutical COM 75886F107 21,365 1,355,651 SH SOLE Salix Pharmaceuticals COM 795435106 1,882 181,133 SH SOLE Symyx Technologies COM 87155S108 205 12,458 SH SOLE Tanox COM 87588Q109 2,451 153,084 SH SOLE Third Wave Technologies COM 88428W108 146 32,357 SH SOLE Trimeris COM 896263100 151,278 3,316,052 SH SOLE Tularik COM 899165104 3,635 367,181 SH SOLE Ventiv Health COM 922793104 112 27,300 SH SOLE Alkermes Conv Notes 6.52% 12/31/09 CONV BONDS 01642TAC2 4,991 3,372,000 PRN SOLE CV Therapeutics 4.75% 3/7/07 CONV BONDS 126667AB0 1,890 2,000,000 PRN SOLE Incyte Notes 5.5% 3/01/2007 CONV BONDS 45337CAC6 3,594 5,000,000 PRN SOLE Regeneron Pharmaceuticals Conv Notes 5.5% 10/17/08 (144A) CONV BONDS 75886FAB3 17,696 18,800,000 PRN SOLE ------- 255,506 =======
COLUMN 8 VOTING AUTHORITY NAME OF ISSUER SOLE SHARED NONE - -------------- ---- ------ ---- Aclara Biosciences 23,199 Alexion Pharmaceuticals 169,663 Amylin Pharmaceuticals 1,064,232 Arena Pharmaceuticals 40,800 Autoimmune 26,100 Encysive Pharmaceuticals 79,312 Exelixis 19,709 Human Genome Sciences 329,977 Incyte 1,671,870 Intrabiotics Pharmaceuticals 53,688 King Parmaceuticals 120,000 Kosan Biosciences 28,935 Medarex 138,111 Neurogen 683,100 Pharmacyclics 35,300 Praecis Pharmaceuticals 50,100 Regeneron Pharmaceutical 1,355,651 Salix Pharmaceuticals 181,133 Symyx Technologies 12,458 Tanox 153,084 Third Wave Technologies 32,357 Trimeris 3,316,052 Tularik 367,181 Ventiv Health 27,300 Alkermes Conv Notes 6.52% 12/31/09 3,372,000 CV Therapeutics 4.75% 3/7/07 2,000,000 Incyte Notes 5.5% 3/01/2007 5,000,000 Regeneron Pharmaceuticals Conv Notes 5.5% 10/17/08 (144A) 18,800,000
-----END PRIVACY-ENHANCED MESSAGE-----